- Home
- Cannabis
Cannabis
Top level international cannabis insights by Adam Isaac Miller | Sep 13/2020
A change in attitude - I read that Japanese people tend to see doctors’ words as indisputable authority; and if doctors disapprove of cannabis, there is little chance for patients to be able to experience what cannabis might do for them. I anticipate in countries like Australia, ...read more
Easier access to medicinal cannabis and soaring sales in Germany, Key Insights by Adam Isaac Miller | Jun 28/2020
Regulations changes - This week the QLD government removed the state approval process required for patients to access medical cannabis. Now doctors will only require Federal approval from the TGA, this should lead to an increase in prescriptions across the State. On the other ...read more
Psychedelics for Mental Health and a Glimpse into the European Cannabis Market, Key Insights by Adam Isaac Miller | Jun 21/2020
The importance of standardization - Authorities across Europe have listed 114 products containing CBD in the European Union’s food-safety alert system since the start of last year, with data indicating that some countries are policing novel-food violations more frequently than ...read more
Canadian Medicinal Cannabis Exports and the Future of Psychedelics, Key Insights by Adam Isaac Miller | Jun 14/2020
Export of cannabis - Canadian businesses exported more dried medical cannabis than ever last year, but that growth is expected to be challenged when the country’s main export destination – Germany – initiates local production later this year. In 2019, federally regulated ...read more
THC Found to Treat Pain and More, Key Insights by Adam Isaac Miller | Jun 07/2020
Cannabis vaporization and pain - A study led by a team of Israeli scientists, published earlier recently in the European Journal of Pain, found precise doses of THC administered via inhaler were effective in reducing pain in neuropathy patients. The randomized placebo-controlled ...read more
Cannabis Farming Accounts For $2.3b In Cash Receipts and the Benefits of Cannabis on Memory Abilities, Key Insights by Adam Isaac Miller | May 31/2020
The wonders of psychedelic compounds - A beautiful excerpt from Franz X. Vollenweider, recent years have seen a burgeoning scientific interest in the neurobiology of altered states of consciousness induced by psychedelic drugs (e.g. such as psilocybin, LSD, and DMT), also driven ...read more
MDMA a Therapeutic Life-Saver for US Veterans in Recent Trial, Key Insights by Adam Isaac Miller | May 24/2020
MDMA for PTSD - MDMA, the active ingredient in the party drug ecstasy, is being touted as a game-changing treatment for post-traumatic stress disorder. It is being trialed in America—and for one army veteran the drug has been a life-saver - this is a truly marvelous video EU is ...read more
The Influence of Covid-19 on Marijuana Smokers (Survey of 1000 Americans)
ARTICLE first printed here It’s been 5 months now since the coronavirus outbreak started. Due to the lockdown policy that was implemented worldwide, people had to come up with ideas to keep themselves healthy, safe and entertained indoors. Needless to say, people had adapted to ...read more
Important Updates From Cannabis in Germany and US Federal Legal Action - Adam Isaac Miller's update | May 03/2020
Cannabis in Germany - A great article by my good friend Alfredo Pascual (Link) - Germany imported 1,032 kilograms (2,275 pounds) of medical cannabis flower for pharmacy dispensing through March 6, an amount that indicates little if any growth versus the average cannabis imported ...read more
The wonders of the cannabis Sativa plant and possible reclassification of CBD - Adam Isaac Miller's update | Apr 26/2020
The marvel of the cannabis plant is endless - here is an excerpt I came across this week speaking about the cannabis Sativa plant. The plant is a wonder of nature, a factory for brain-altering chemicals unlike any the world has ever seen. But there is a tremendous amount of ...read more
Cannabis Corner, Key Insights by Adam Isaac Miller | Apr 19/2020
CBD and anxiety - It is very likely that CBD will eventually become a treatment for anxiety (amongst other things). A study conducted by researchers at the Johns Hopkins University School of Medicine and published in the Journal of Substance Abuse Treatment asked 200 people with ...read more
Cannabis Corner, Key Insights by Adam Isaac Miller | Apr 13/2020
A note on psychedelics - Before they were banned about a half-century ago, psychedelic drugs like LSD and psilocybin showed promise for treating conditions including alcoholism and some psychiatric disorders. Researchers say it's time for regulators, scientists, and the public to ...read more
Cannabis Corner, Key Insights by Adam Isaac Miller | Apr 06/2020
Based on limited time, I’ve postponed top-level insights this week. I do know to acknowledge the great work the ACI is doing in the U.K. to create a CBD Safety Certification programme. I’ve previously commented on the need for standards for CBD products in emerging markets. The ...read more
Cannabis Corner, Key Insights by Adam Isaac Miller | Mar 29/2020
Differentiated delivery formats are still an area of uncharted territory amongst cannabis companies. There are several products in the market with minimal pharmacokinetic data to support bi-availability, yet this has not appeared to be an issue to the growing number of patients ...read more
Cannabis Corner, Key Insights by Adam Isaac Miller | Mar 22/2020
This week I read that overall U.S. sale of legalised cannabis was expected to reach $13.6 billion throughout 2019, up 32% from 2018’s total of $10.3 billion. I wonder if the economic slowdown which COVID-19 has created will make cannabis legalisation at the federal and state ...read more
Cannabis Corner, Key Insights by Adam Isaac Miller | Mar 08/2020
Once again, the WHO is expecting to delay the vote affecting the scheduling of THC and CBD. At a time where CBD across the EU is under fire, a firm position from the WHO would be welcomed by the industry. However, countries have welcomed the expected postponement of the vote ...read more
Cannabis Corner, Key Insights by Adam Isaac Miller | Mar 01/2020
The coronavirus outbreak in China likely will benefit American hemp companies that compete with Chinese suppliers on the global and domestic markets. And this newest issue underscores the vulnerabilities in the global marketplace that vape and other cannabis and hemp companies ...read more
Cannabis Corner, Key Insights by Adam Isaac Miller | Feb 16/2020
Europe offers growth opportunities for the next wave of cannabis organisations. The UK, Germany, Italy and the Netherlands already have legal systems in place for medicinal cannabis and France and Spain are currently reviewing key legislative reform to align themselves with ...read more
Cannabis Corner, Key Insights by Adam Isaac Miller | Feb 09/2020
Brazil and New Zealand share common fates as the two countries open up patients' ability to access medical cannabis. Both countries emphasise GMP only products, meaning companies that intend to import into these countries require manufacture under EUGMP (or equivalent). This is ...read more
Cannabis Corner, Key Insights by Adam Isaac Miller | Jan 12/2020
3,682 medicinal cannabis prescriptions were approved via SAS Category B in December 2019. Prescriptions throughout 2019, increased month on month excluding November which dropped by 190 prescriptions compared to October. The only drop in prescriptions recorded before this was in ...read more
Cannabis Corner, Key Insights by Adam Isaac Miller | Jan 26/2020
The growing concern over calories and hangovers is driving more millennials to replace alcohol with cannabis in their social life. A recent study by Future research found US millennials drink far less alcohol than previous generations: The percentage of college students who drink ...read more
Cannabis Corner, Key Insights by Adam Isaac Miller | Jan 19/2020
Cannabis production may be too risky and restrictive for new cultivation companies. High input costs, unstable genetics, and a steep learning curve lead to non-viable output costs for cannabis companies. The new entrants into the market are also seeing high barriers to entry ...read more